FDA approves first gene therapy for Haemophilia B
Hemgenix, the first gene therapy for adults with Haemophilia B has been approved by the US Food and Drug Administration (FDA).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
